The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415
Supportive Care in Cancer · 2024
DOI: 10.1007/s00520-024-08717-7 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Nancy E Avis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC, 27157, USA. navi…. Hauptthemen laut MEDLINE: Breast Neoplasms, Fatigue, Anthracyclines, Cancer Survivors. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Wake Forest University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
To examine the differential effect of non- and anthracycline-based chemotherapy on fatigue over 12 months post-diagnosis among breast cancer survivors.
Methods
This study is based on a prospective Wake Forest NCI Community Oncology Research Program (NCORP) multicenter cohort study (WF-97415) of women with stage I to III breast cancer and non-cancer controls. Analyses compared those: 1) receiving, or 2) not receiving anthracycline chemotherapy, 3) receiving aromatase inhibitors (AIs) without chemotherapy, with 4) a comparator group without a history of cancer. In-person clinic assessments were conducted at: baseline (prior to chemotherapy or start of AI therapy), and 3 and 12 months after baseline. The Functional Assessment of Chronic Illness Therapy-Fatigue scale was the primary outcome. Estimated least squares means by group using mixed models with a random subject effect, fixed effects of time and group, and the interaction between time and group was used to compare groups across time, controlling for age, comorbidities, and treatment variables.
Results
Among 284 women (mean age = 53.4 years, sd 11.9 years), there was a significant (p < 0.0001) group by time interaction, with a sharp increase in fatigue at 3 months in the two chemotherapy groups in comparison to the non-chemotherapy and non-cancer controls. The two chemotherapy groups did not significantly differ in fatigue at any time point.
Conclusion
Women with breast cancer who receive non- or anthracycline-based chemotherapy experience similar trends in and levels of fatigue within the first year of treatment and greater fatigue than women receiving AIs alone or women without breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC, 27157, USA. navis@wakehealth.edu.
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC, 27157, USA.
- Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, USA.
- Section On Cardiovascular Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
- Department of Internal Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
- Wake Forest University
Zitieren
APA
Avis, N. E., Levine, B. J., Klepin, H. D., Mihalko, S. L., Brubaker, P. H., Moore, T., Ladd, A. C., Dent, S. F., Hackney, M. H., Ky, B., Ntim, W. O., Wagner, L. I., Weaver, K. E., Hundley, W. G., & UPBEAT study team (2024). The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08717-7
Vancouver
Avis NE, Levine BJ, Klepin HD, Mihalko SL, Brubaker PH, Moore T, et al. The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08717-7
BibTeX
@article{Avis2024,
author = {Avis, Nancy E and Levine, Beverly J and Klepin, Heidi D and Mihalko, Shannon L and Brubaker, Peter H and Moore, Tonya and Ladd, Amy C and Dent, Susan F and Hackney, Mary Helen and Ky, Bonnie and Ntim, William O and Wagner, Lynne I and Weaver, Kathryn E and Hundley, W Gregory and UPBEAT study team, UPBEAT study team},
title = {The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415},
journal = {Supportive Care in Cancer},
year = {2024},
doi = {10.1007/s00520-024-08717-7}
}
EUVIMED